| Literature DB >> 36171358 |
Tim J Knobbe1,2, Daan Kremer3, Michele F Eisenga3, Eva Corpeleijn4, Coby Annema5, Joke M Spikman6, Gerjan Navis3, Stefan P Berger3, Stephan J L Bakker3.
Abstract
Impaired interplay between sensory and motor function may be an important, often overlooked cause of the decreased daily functioning and impaired health-related quality of life (HRQoL) of kidney transplant recipients (KTR). We assessed this interplay using a hand dexterity test, and investigated its potential associations with daily functioning and HRQoL among KTR enrolled at the TransplantLines Biobank and Cohort Study. A total of 309 KTR (58% male, mean age 56 ± 13 years) at median 4 [IQR: 1-11] years after transplantation were included. Impaired hand dexterity, as defined by a test performance slower than the 95th percentile of an age- and sex-specific reference population, was observed in 71 (23%) KTR. Worse hand dexterity was independently associated with worse performance on almost all measures of physical capacity, activities of daily living and societal participation. Finally, hand dexterity was independently associated with physical HRQoL (standardized beta - 0.22, 95%CI - 0.34 to - 0.09, P < 0.001). In conclusion, impaired interplay between sensory and motor function, as assessed by hand dexterity, is prevalent among KTR. In addition, poor hand dexterity was associated with impaired daily functioning and limited physical HRQoL. Impaired interplay between sensory and motor function may be therefore an important, hitherto overlooked, phenomenon in KTR.Entities:
Mesh:
Year: 2022 PMID: 36171358 PMCID: PMC9519570 DOI: 10.1038/s41598-022-19952-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Baseline characteristics and associations with hand dexterity.
| Total population | Results of linear regression analyses | ||||
|---|---|---|---|---|---|
| Univariable analyses | Analyses adjusted for sex and age | ||||
| St. β (95% CI) | St. β (95% CI) | ||||
| Demographics | |||||
| Male sex, | 180 (58) | 0.29 (0.18 to 0.40) | < 0.001 | – | – |
| Age, years | 56 ± 13 | 0.44 (0.34 to 0.54) | < 0.001 | – | – |
| Educational level, | |||||
| Low | 114 (38) | Reference | n/a | Reference | n/a |
| Medium | 114 (38) | − 0.21 (− 0.33 to − 0.08) | 0.001 | − 0.09 (− 0.20 to 0.02) | 0.1 |
| High | 304 (25) | − 0.20 (− 0.33 to − 0.08) | 0.001 | − 0.18 (− 0.29 to − 0.07) | < 0.001 |
| Caucasian, | 297 (4) | − 0.08 (− 0.19 to 0.04) | 0.2 | − 0.08 (− 0.17 to 0.02) | 0.1 |
| Body mass index, kg/m2 | 28 ± 5 | 0.07 (− 0.04 to 0.18) | 0.2 | 0.11 (0.01 to 0.21) | 0.025 |
| Primary kidney disease, | |||||
| Unknown | 46 (15) | Reference | n/a | Reference | n/a |
| Inflammatory disease | 103 (33) | 0.02 (− 0.14 to 0.18) | 0.8 | 0.03 (− 0.11 to 0.16) | 0.7 |
| Congenital and hereditary kidney disease | 83 (27) | − 0.13 (− 0.28 to 0.03) | 0.1 | − 0.13 (− 0.26 to 0.01) | 0.062 |
| Kidney vascular disease, excl. vasculitis | 27 (9) | 0.02 (− 0.11 to 0.15) | 0.8 | − 0.02 (− 0.13 to 0.10) | 0.8 |
| Diabetic kidney disease | 20 (7) | 0.17 (0.04 to 0.30) | 0.010 | 0.17 (0.06 to 0.28) | 0.003 |
| Other | 30 (10) | − 0.02 (− 0.15 to 0.12) | 0.8 | − 0.03 (− 0.14 to 0.09) | 0.6 |
| Diabetes, | 86 (28) | 0.22 (0.11 to 0.33) | < 0.001 | 0.17 (0.08 to 0.27) | < 0.001 |
| Anemia, | 96 (31) | 0.08 (− 0.03 to 0.19) | 0.2 | 0.11 (0.01 to 0.20) | 0.032 |
| Alcohol intake, units/week, | |||||
| None | 109 (37) | Reference | n/a | Reference | n/a |
| < 7 units/week | 118 (41) | − 0.09 (− 0.22 to 0.04) | 0.2 | − 0.07 (− 0.19 to 0.04) | 0.2 |
| ≥ 7 units/week | 64 (22) | − 0.03 (− 0.16 to 0.11) | 0.7 | − 0.09 (− 0.21 to 0.02) | 0.1 |
| Smoking history, | 150 (49) | − 0.03 (− 0.09 to 0.14) | 0.6 | − 0.07 (− 0.17 to 0.03) | 0.2 |
| Dialysis before transplantation, | 188 (61) | 0.16 (0.05 to 0.27) | 0.006 | 0.11 (0.01 to 0.21) | 0.025 |
| Living donor, | 171 (55) | − 0.17 (− 0.29 to − 0.06) | 0.002 | − 0.08 (− 0.17 to 0.02) | 0.1 |
| Delayed graft functioning, | 32 (11) | 0.09 (-0.02 to 0.21) | 0.1 | 0.03 (− 0.06 to 0.13) | 0.5 |
| Time after transplantation, years† | 4 [1 to 11] | 0.07 (− 0.04 to 0.18) | 0.2 | 0.04 (− 0.05 to 0.14) | 0.4 |
| History of rejection(s), | 31 (10) | 0.07 (− 0.05 to 0.18) | 0.2 | 0.09 (− 0.01 to 0.19) | 0.064 |
| Postoperative CMV infection, | 44 (15) | 0.08 (− 0.03 to 0.20) | 0.2 | 0.04 (− 0.06 to 0.14) | 0.4 |
| Feeling of anxiety, | 68 (23) | 0.01 (− 0.10 to 0.13) | 0.8 | 0.06 (− 0.04 to 0.16) | 0.2 |
| Moderate to severe depressive symptoms, | 15 (5) | − 0.10 (− 0.21 to 0.02) | 0.097 | − 0.05 (− 0.15 to 0.05) | 0.3 |
| Hemoglobin, g/dL | 13.5 ± 1.8 | 0.03 (− 0.14 to 0.09) | 0.7 | − 0.15 (− 0.25 to − 0.05) | 0.004 |
| Leukocyte count, 109/L | 7.5 ± 2.2 | 0.01 (− 0.10 to 0.13) | 0.8 | 0.02 (− 0.07 to 0.12) | 0.6 |
| C-reactive protein, mg/L‡ | 1.9 [0.7 to 4.1] | 0.14 (0.03 to 0.25) | 0.014 | 0.11 (0.01 to 0.21) | 0.025 |
| Plasma albumin, g/dL | 4.3 ± 0.3 | − 0.18 (− 0.29 to − 0.07) | 0.002 | − 0.11 (− 0.21 to − 0.01) | 0.025 |
| eGFR, mL/min/1.73m2 | 52 ± 17 | − 0.11 (− 0.22 to 0.01) | 0.064 | − 0.07 (− 0.17 to 0.02) | 0.1 |
| Prednisolone, | 300 (97) | 0.11 (− 0.00 to 0.22) | 0.06 | 0.08 (− 0.02 to 0.17) | 0.1 |
| Calcineurin inhibitor, | 255 (83) | − 0.08 (− 0.19 to 0.04) | 0.2 | − 0.01 (− 0.11 to − 0.09) | 0.9 |
| Proliferation inhibitor, | 267 (86) | − 0.07 (− 0.18 to 0.05) | 0.2 | − 0.06 (− 0.16 to 0.04) | 0.2 |
| mTOR inhibitor, | 12 (4) | − 0.05 (− 0.17 to 0.06) | 0.4 | − 0.04 (− 0.14 to 0.05) | 0.4 |
Normally distributed data are presented as mean ± standard deviation, non-normally distributed data as median [interquartile range], and categorical data as number (valid %). †: Variables were log2 transformed to meet assumptions of linear regression analyses. Higher positive standardized beta coefficients indicate slower performance of the 9-hole peg test, and hence worse hand dexterity. Data regarding educational level, alcohol intake, smoking history, history of rejection, postoperative CMV infection, feeling of anxiety and moderate to severe depressive symptoms, were missing in 5 (2%), 18 (6%), 1 (0.3%), 7 (2%), 10 (3%), 7 (2%) and 8 (3%) participants, respectively. Abbreviations: CI, confidence interval; CMV, cytomegalovirus; eGFR, estimated glomerular filtration rate; mTOR, mammalian target of rapamycin; St. β, standardized beta.
Figure 1Distribution of Z-scores of the time required to perform the hand dexterity test calculated based on age- and sex-specific mean and standard deviation values of a reference population. The dashed line represents the age- and sex-specific mean + 1.645 times the age- and sex-specific standard deviation of a reference population, which translates to the 95th percentile of the age- and sex-specific reference population[12]. Participants right to this line were defined as having an impaired hand dexterity.
Figure 2Scatterplot of age and the time to succeed the hand dexterity test, presented per sex. The solid lines represent the association between age and hand dexterity per sex, and the shaded area represents its 95% confidence interval. The dashed lines represent the age- and sex-specific mean + 1.645 times the age- and sex-specific standard deviation of a reference population, stratified by sex[12]. As such, they represent the 95th percentile of an age and sex-specific reference population. Participants above the dashed lines were defined as having an impaired hand dexterity.
Results of regression analyses with hand dexterity as independent variable and measures of daily functioning as dependent variable.
| Physical capacity and ADL | Crude | Model 1 | Model 2 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Activities of daily living | St. β (95% CI) | St. β (95% CI) | St. β (95% CI) | ||||||
| Timed-up-and-go test, s‡ | 250 | 0.36 (0.24 to 0.48) | < 0.001 | 250 | 0.35 (0.22 to 0.49) | < 0.001 | 246 | 0.29 (0.16 to 0.43) | < 0.001 |
| Five time sit to stand test, s‡ | 258 | 0.34 (0.22 to 0.45) | < 0.001 | 258 | 0.35 (0.21 to 0.48) | < 0.001 | 255 | 0.24 (0.11 to 0.38) | < 0.001 |
| 4-m walk test, s‡ | 263 | 0.26 (0.14 to 0.38) | < 0.001 | 263 | 0.25 (0.11 to 0.38) | < 0.001 | 259 | 0.18 (0.04 to 0.32) | 0.012 |
Model 1: adjusted for age and sex. Model 2: model 1 additionally adjusted for educational level, body mass index, diabetes, dialysis before transplantation, time since transplantation, hemoglobin, C-reactive protein and plasma albumin. †: Per 5 s increment of the hand dexterity test. ‡: Reasons for not performing the physical assessments were an inability to walk safely or walking caused too much pain (n = 14), or because of time constraints (n = 28). Results are presented in standardized beta (st. β) coefficients for linear regression analyses and in odds ratios (OR) for logistic regression analyses, with 95% confidence intervals (95%CI).
Analyses with hand dexterity as potential determinant of health-related quality of life.
| SF-36 | Health-related quality of life | ||||
|---|---|---|---|---|---|
| Physical component scale | Mental component scale | ||||
| St. β (95% CI) | P | St. β (95% CI) | |||
| Crude | 309 | − 0.24 (− 0.35 to − 0.13) | < 0.001 | − 0.05 (− 0.17 to 0.06) | 0.3 |
| Model 1 | 309 | − 0.29 (− 0.41 to − 0.16) | < 0.001 | − 0.15 (− 0.28 to − 0.03) | 0.019 |
| Model 2 | 303 | − 0.18 (− 0.30 to − 0.05) | 0.007 | − 0.08 (− 0.22 to 0.06) | 0.3 |
Model 1: adjusted for sex and age. Model 2: model 1 additionally adjusted for educational level, body mass index, diabetes, dialysis before transplantation, time since transplantation, hemoglobin, C-reactive protein and plasma albumin. Results are presented in standardized beta (st. β) coefficients with 95% confidence intervals (95%CI). Abbreviations: SF-36, Short Form-36; st. β, standardized beta; CI, confidence interval.